CARsgen Therapeutics boosts share capital by 4.15% through HKD 19.84 placement and option exercises

Bulletin Express05-26

CARsgen Therapeutics Holdings Limited announced in its 26 May 2026 Next Day Disclosure Return that it has expanded its issued share capital through a combination of a private placement and employee option exercises.

The key transaction was the completion of a subscription of 23.70 million new ordinary shares under the company’s general mandate at HKD 19.84 per share on 26 May 2026. The placement represents 4.15 % of the company’s issued share base immediately prior to the issue.

In addition, between 6 May and 26 May 2026, employees (excluding directors) exercised 33,250 share options granted under the Post-IPO Share Option Scheme adopted on 30 April 2021. Exercise prices ranged from HKD 17.51 to HKD 23.80 per share.

Following these transactions, the number of issued shares (excluding treasury shares) rose to 594.68 million from 570.94 million, while total issued shares (including treasury shares) reached 602.49 million. Treasury shares remained unchanged at 7.82 million.

The company also holds 455,000 shares that were repurchased in October 2025 but have not yet been cancelled, acquired at average prices of HKD 17.08 and HKD 16.58.

The board confirmed that all share issues were duly authorised and executed in compliance with Hong Kong Listing Rules and other applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154511225?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 23:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154511225","market":"hk","top_or_hot":-1,"title":"CARsgen Therapeutics boosts share capital by 4.15% through HKD 19.84 placement and option exercises","media":"Bulletin Express","content":"<p>CARsgen Therapeutics Holdings Limited announced in its 26 May 2026 Next Day Disclosure Return that it has expanded its issued share capital through a combination of a private placement and employee option exercises.</p>\n<p>The key transaction was the completion of a subscription of 23.70 million new ordinary shares under the company’s general mandate at HKD 19.84 per share on 26 May 2026. The placement represents 4.15 % of the company’s issued share base immediately prior to the issue.</p>\n<p>In addition, between 6 May and 26 May 2026, employees (excluding directors) exercised 33,250 share options granted under the Post-IPO Share Option Scheme adopted on 30 April 2021. Exercise prices ranged from HKD 17.51 to HKD 23.80 per share.</p>\n<p>Following these transactions, the number of issued shares (excluding treasury shares) rose to 594.68 million from 570.94 million, while total issued shares (including treasury shares) reached 602.49 million. Treasury shares remained unchanged at 7.82 million.</p>\n<p>The company also holds 455,000 shares that were repurchased in October 2025 but have not yet been cancelled, acquired at average prices of HKD 17.08 and HKD 16.58.</p>\n<p>The board confirmed that all share issues were duly authorised and executed in compliance with Hong Kong Listing Rules and other applicable regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARsgen Therapeutics boosts share capital by 4.15% through HKD 19.84 placement and option exercises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARsgen Therapeutics boosts share capital by 4.15% through HKD 19.84 placement and option exercises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 23:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARsgen Therapeutics Holdings Limited announced in its 26 May 2026 Next Day Disclosure Return that it has expanded its issued share capital through a combination of a private placement and employee option exercises.</p>\n<p>The key transaction was the completion of a subscription of 23.70 million new ordinary shares under the company’s general mandate at HKD 19.84 per share on 26 May 2026. The placement represents 4.15 % of the company’s issued share base immediately prior to the issue.</p>\n<p>In addition, between 6 May and 26 May 2026, employees (excluding directors) exercised 33,250 share options granted under the Post-IPO Share Option Scheme adopted on 30 April 2021. Exercise prices ranged from HKD 17.51 to HKD 23.80 per share.</p>\n<p>Following these transactions, the number of issued shares (excluding treasury shares) rose to 594.68 million from 570.94 million, while total issued shares (including treasury shares) reached 602.49 million. Treasury shares remained unchanged at 7.82 million.</p>\n<p>The company also holds 455,000 shares that were repurchased in October 2025 but have not yet been cancelled, acquired at average prices of HKD 17.08 and HKD 16.58.</p>\n<p>The board confirmed that all share issues were duly authorised and executed in compliance with Hong Kong Listing Rules and other applicable regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1154511225","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154511225","pubTimestamp":1779807935,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CARsgen Therapeutics Holdings Limited announced in its 26 May 2026 Next Day Disclosure Return that it has expanded its issued share capital through a combination of a private placement and employee...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"科济药业通过19.84港元配售和行使期权将股本增加4.15%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARsgen Therapeutics Holdings Limited announced in its 26 May 2026 Next Day Disclosure Return that it has expanded its issued share capital through a combination of a private placement and employee option exercises.\nThe key transaction was the completion of a subscription of 23.70 million new ordinary shares under the company’s general mandate at HKD 19.84 per share on 26 May 2026. The placement represents 4.15 % of the company’s issued share base immediately prior to the issue.\nIn addition, between 6 May and 26 May 2026, employees (excluding directors) exercised 33,250 share options granted under the Post-IPO Share Option Scheme adopted on 30 April 2021. Exercise prices ranged from HKD 17.51 to HKD 23.80 per share.\nFollowing these transactions, the number of issued shares (excluding treasury shares) rose to 594.68 million from 570.94 million, while total issued shares (including treasury shares) reached 602.49 million. Treasury shares remained unchanged at 7.82 million.\nThe company also holds 455,000 shares that were repurchased in October 2025 but have not yet been cancelled, acquired at average prices of HKD 17.08 and HKD 16.58.\nThe board confirmed that all share issues were duly authorised and executed in compliance with Hong Kong Listing Rules and other applicable regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154511225","isCrawlerRequest":true}